The University of Southampton

Just Out of Reach: Restoring Sensation with Prosthetic Technology

In the sensing and sensors lecture, we were shown an example of a prosthetic limb in 2021 with haptics responsive enough that a blindfolded 85-year-old could pick up a hollow eggshell without damaging it1.

This really made me think about the functions you’d need to replicate in a prosthetic arm beyond it being just an appendage for it to fulfill all the roles of the lost limb. I’d only come across haptics being used to extend a user’s ‘self’ in videogame hardware, but with some reflection and research (including on WW2 planes using haptics to forewarn pilots of stalls2) it made sense that the device increasingly becomes an extension of the user with improvements to effective information flow.

So what other sensations are there to improve this link? What other advancements have there been? The sense that immediately comes to mind is temperature, but following that, pain. Pain and discomfort naturally protect us from harm, driving you to avoid potential injury.

In 2018, researchers at Johns Hopkins’ University displayed an electronic synthetic skin called “e-dermis”. A structure of rubber and fabric with sensor “nerve endings” could interact with peripheral nerves of amputees, feeding back curvature and sharpness as “touch” and “pain” respectively. The e-dermis can be implemented on existing prosthetics, enabling users to tell whether they were holding a sharp or smooth object3.

Later in 2020, RMIT University (Royal Melbourne Institute of Technology) developed another electronic synthetic silicone skin. Vanadium oxide’s electronic behaviour changes in response to temperatures above 65˚C, creating a temperature trigger when integrated into the “skin” for pain decision making. Researchers suggested potential applications in non-invasive skin-grafts upon further development, with the “brain-mimicking circuit” having adjustable thresholds to modify sensitivity4.

The temperature sensitive synthetic skin from RMIT

For anyone reading on these advancements there’s a point that probably stands out though. Do the advantages of simulated pain outweigh the discomfort a prosthetic could inflict on the user when the sensor is on a repairable part?

“After many years, I felt my hand, as if a hollow shell got filled with life again,”-Anonymous principal volunteer tester3.

When implementing the “e-dermis”, stimuli produced by the synthetic skin matched sensations in users’ phantom limbs. Additionally, interaction with peripheral nerves is increasingly well documented to reduce phantom limb pain5,6,7. If reactive pain and sensory feedback can reduce persistent phantom limb pain in amputees, improving brain body mapping for prostheses, the very pain and discomfort we want to avoid could act to unify prosthetic and person.

I was also curious what advancements in sensory prosthetics could do for those paralysed by extension. A 2025 study by researchers at the University of Chicago8 worked with individuals with spinal cord injuries. Electrodes were implanted into the sensory and motor regions of the brain, allowing not only control of a robotic arm and hand, but sensation through it. Subjects could feel edges, shapes and movement through their connection to the robotic arm.

Amazingly, subjects had such good control of the limb they could even drive cars (in simulation).

Pictured use of the robotic hand, taken from the University of Chicago Medicine site.

The development of sensation in prosthetics is so much further than I realised, where else could these technologies go? Where else might they end up?  If pain, touch, and temperature feedback can be integrated into artificial limbs, could future developments allow individuals to experience a completely artificial yet fully sensory body?

References

Human-Animal Hybrid Brains: A Dr. Frankenstein Dilemma

Introduction:

While studying for a debate regarding the use of embryonic stem cells (ESCs) in research, I stumbled across articles about organoids. I remembered them being mentioned in one of our earlier lectures, therefore these articles peaked my interest. So I dug deeper. What interested me was the slightly morbid idea of growing a human brain and what that means. This digging led to another branch of this scientific, dystopian tree: brain chimeras. In this blog, I will be discussing why brain organoids and chimeras are made, what they are used for and what ethical issues rise.

Are we as scientists, justifying the use of these chimeras the same way Dr. Frankenstein justified the creation of his monster, selfishly in pursuit of greater knowledge despite the pain and suffering this may create?

What are they and how are they made?

Organoids are 3D, self-organised tissue cultures made from stem cells. They are made by using iPSCs (induced pluripotent stem cells) which are made from adult somatic cells. This is done by reprogramming these somatic cells using transcription factors to make the cell pluripotent similar to ESCs.

To grow these organoids the iPSCs are cultured to form an embryoid body (EB) which mimics the features of an early stage embryo. This is exposed to different mediums to encourage differentiation into brain cells then grown in a growth medium.

Organoids can be made with human stem cells and animal stem cells. This results in brain Chimeras which are made by engrafting human foetal tissue/iPSCs into a neonatal animal (e.g. mouse) brain.

Why are they important?

We all know someone who is battling with a neurological condition. Many of these conditions are debilitating, ruin lives and have high mortality rates. This highlights the significance of this research.

One in two of us will suffer with dementia in our lifetime. Therefore, research into neurodegenerative disease is more important than ever before.

Although these organoids and human-animal brain chimeras are relatively new there has been a tremendous volume of studies which use this technology. They can offer important insight into the progression of neurodegenerative disease leading to new treatments. However, one could argue that these ‘brains’ are still fundamentally different and less complex than a real human brain as most animals are biologically very different and display different symptoms of neurological problems.

The issue

The main debate lies with the idea that human brain organoids or human-animal brain chimeras could be capable of intelligent thought. This raises many concerns as currently organoids hold no legal or moral rights within science. Are these chimeras thinking the same as a human may think? Are they self aware? More complex than say an ordinary mouse? And why should this matter?

There are significant regulations when using hESCs for research, such as the 14 day rule, however, organoids and human-animal chimeras are not regulated the same way, it does not even require a license as long as it does not use hESCs. Why is this?

These brain organoids and chimeras have the same moral status as many animals that are used in research. Should this be the case?

There is no right answer here as you cannot possibly know what a chimera or brain organoid could be thinking.

Conclusions and Reflections

Prior to researching this topic I did not appreciate the complexity and possible future of these models, I had a similar initial reaction to using any animal model; that it is a cruel and disturbing idea. However, animal models and hESCs have contributed greatly to the world of science, without them many treatments (HIV medication, cancer medications, vaccines) would not have been developed. This shows how important in vivo research is and these organoid/chimeric models may just add to the possibilities.

Contrary to this, I was surprised to find that making an organoid does not require any sort of formal license. I believe organoids should be treated with the same moral significance as hESCs as there is a grey area regarding their consciousness.

In conclusion, organoids and chimeric models raise many ethical and thought provoking questions, however, they offer invaluable research opportunities which could help many people, although they should be treated with more moral significance similar to that of hESCs.

References:

CAPPS B. Do Chimeras Have Minds?: The Ethics of Clinical Research on a Human–Animal Brain Model. Cambridge Quarterly of Healthcare Ethics. 2017;26(4):577-591. doi:10.1017/S0963180117000093

Grenier, K., Kao, J. & Diamandis, P. Three-dimensional modeling of human neurodegeneration: brain organoids coming of age. Mol Psychiatry 25, 254–274 (2020). https://doi.org/10.1038/s41380-019-0500-7

Kwisda, K., White, L. & Hübner, D. Ethical arguments concerning human-animal chimera research: a systematic review. BMC Med Ethics 21, 24 (2020). https://doi.org/10.1186/s12910-020-00465-7

Eigenhuis KN, Somsen HB, van der Kroeg M, Smeenk H, Korporaal AL, Kushner SA, de Vrij FMS, van den Berg DLC. A simplified protocol for the generation of cortical brain organoids. Front Cell Neurosci. 2023 Apr 4;17:1114420. doi: 10.3389/fncel.2023.1114420. PMID: 37082206; PMCID: PMC10110973.

Further Reflection on the Question “Shall We Keep, Extend, or Ban Embryo Testing?”

During the stem cell debate workshop, I argued in favour of extending the 14-day embryo rule for the sake of the exercise. However, when asked about my true stance, I realised I didn’t have a clear answer. I felt conflicted because, while I didn’t condemn other researchers using embryos, I would never want to handle them myself. I have always strongly believed in human life – even the potential of human life. The thought of taking away this potential makes me feel very uneasy. This made me question whether I was simply unwilling—or perhaps unable—to extend my personal morals to others. I set out to discover more to help me come to a conclusion…

Why are embryos being used and where do they come from?

First, I strived to find out a little more about where the embryos are sourced and what is being done with them. I learned they are mainly derived from excess in-vitro fertilization (IVF) embryos and are donated for research purposes with informed consent. Strict regulations, such as the 14-day rule, limit research to early developmental stages before formation of the primitive streak. I also learned embryonic stem cells (ESCs) are studied for their potential in regenerative medicine, treating conditions such as Parkinson’s disease, spinal cord injuries, and heart disease.

So should we ban embryo testing?

Based on this information, I cannot say I’d support a complete ban. Excess embryos created for the sake of IVF should not be simply disposed of. This would be wasteful. Furthermore, lifesaving research has been done using embryonic stem cells. How could I condemn the loss of potential life if it means existing life has to suffer?

I then reached out to Dr Salah Elias who works with embryonic stem cells to ask for his opinion from an academic standpoint. While he did not directly share his own beliefs, he directed me to some useful recent publications:

The researchers mentioned in Dr Elias’ email are involved in synthesis of synthetic human embryos. Although they are not truly “synthetic” as they originate from embryonic stem cells cultured in the laboratory, they require a much smaller number of traditional embryos and therefore may be much more ethical as well as more readily available.

So shall we extend the 14-day rule?

Okay, so I’ve ruled out a complete ban, but how has Dr Elias’ papers influenced my opinions?

First, I must mention my research that led me to the He Jiankui Affair (2018) where I was horrified to learn Jiankui edited embryos during IVF using CRISPR-Cas9 technology and implanted them into a mother, resulting in the birth of twins Lulu and Nana.

This brought up the worry that extending the rule sets a precedent for continuous boundary-pushing, potentially leading some scientists to believe they have the right to create and bring a whole child to birth in the name of science. However, upon further reflection I do not think this incident was the result of lax boundaries – the laws were still in place, Jiankui just chose to break them. Furthermore, Jiankui was punished severely – he was sentenced to three years in prison, fined 3 million yuan and banned from working in reproductive medicine, reassuring me those who overstepped these laws would never be praised no matter how “revolutionary” their work proved to be.

While this realisation eased me a little, with the possibility of synthetic human embryos I do not believe it is necessary currently to extend the 14 day rule. By maintaining this rule and finding alternative approaches, we uphold a clear ethical framework that respects the potential of human life while still allowing for valuable research in early development and regenerative medicine. Until there is a compelling and widely accepted reason to extend this limit, I believe it is both responsible and reasonable to continue adhering to this boundary.

The Future of Joint Replacements: Robotics and 3D Printing

Looking back on the topics this module has covered so far this year, joint replacements and its future prospects particularly resonated with me. This is because a few of my family members have had knee replacements and for the most part it has completely changed their lives for the better. However, this is not always the case for people receiving joint replacements, and I believe further research into joint replacements is vital. So in this blog, I am going to explore the current problem with prosthetic joints and the exciting future prospects that have the potential to and are currently revolutionising joint replacements.

The Current Problem

The most common cause of replacement failure and revision of surgery is aseptic loosening, which is the loosening of the prosthesis from bone in the absence of infection or trauma. The main causes of aseptic loosening include Mechanical wear, particle debris, poor initial fixation and bone resorption and with the number of joint replacements surgeries increasing, it is paramount that we continue the research into the causes of aseptic loosening as this can reduce the revision burden. you can read more about the causes of aseptic loosening here: https://www.sciencedirect.com/science/article/pii/S1877132720300385

Robotic-Assisted Joint Replacement

One of the most crucial developments in joint replacement is robotic-assisted surgery. Specialised sensors and software utilised by robots allow for more precise operations. This is because before surgery, it is used to produce a 3D image of the patients joint, therefore giving the surgeon the ability to create a customised surgical plan and the ideal implant sizes for that patient. Furthermore, it greatly reduces the risk of poor initial fixation (one of the causes for aseptic loosening) as the joint prosthetic is better aligned and stable due to the customised surgical plan. You can watch this video, which answers some of the questions around robotic-assisted surgery and how it compares to traditional surgery:

3D Printing: The Era of Custom Implants

Image highlighting how 3D printing has innovated knee replacementsRevolutionizing Medicine: 3D Printed Knee Replacement Innovations

Another revolutionary advancement in joint prosthetics is 3D printing, which is enabling the production of fully customisable prosthetics and the creation of complex surgical models. It further enhances surgical precision, improving patient outcomes and expanding our understanding of what is surgically possible. Some of the benefits already being seen from 3D printing are enhanced fit and comfort, improved biocompatibility and integration, reduced surgery time and minimised complications. Overall, I believe that the 3D printing of prosthetics offers an exciting improvement to patient well-being following joint surgery, but it does raise the interesting question of will the future bring about implants constructed from bioengineered materials that integrate with our body flawlessly? Only time will tell, but current developments of scaffolds and hydrogels show promise. You can read more about 3D printing in surgery here: https://highsurgery.com/3d-printing-in-surgery-customizing-implants-and-surgical-models/

A Future Worth Anticipating

To me, it is clear that joint replacements are beginning to shift from a standardised mechanical solution to a more precise, personalised and effective approach. However, the development of joint prosthetics is far from over, and I believe that it is essential to utilise the continuing technological advancements to better joint replacements to further improve patient well-being post op.

References:

admin (2025). 3D Printing in Surgery: Customizing Implants and Surgical Models – HighSurgery. [online] HighSurgery. Available at: https://highsurgery.com/3d-printing-in-surgery-customizing-implants-and-surgical-models/.

Jones, M.D. and Buckle, C.L. (2020). How does aseptic loosening occur and how can we prevent it? Orthopaedics and Trauma, 34(3). doi:https://doi.org/10.1016/j.mporth.2020.03.008.

Mills, J. (2024). The Evolution of Joint Replacement Surgery: How Technology is Changing Recovery Times. [online] Intelligent Living. Available at: https://www.intelligentliving.co/joint-replacement-surgery-techn-recovery/ [Accessed 28 Mar. 2025].

Ning, L., Gil, C., Hwang, B., Theus, A.S., Perez, L., Tomov, M.L., Bauser-Heaton, H. and Vahid Serpooshan (2020). Biomechanical factors in three-dimensional tissue bioprinting. 7(4), pp.041319–041319. doi:https://doi.org/10.1063/5.0023206.

www.orthoinfo.org. (n.d.). Robotic-Assisted Joint Replacement – OrthoInfo – AAOS. [online] Available at: https://www.orthoinfo.org/en/treatment/robotic-assisted-joint-replacement/.

Gene Editing: Does it Hurt those it’s Meant to Help?

When we first looked at gene editing, I had mixed feelings. As some who studies engineering, I believe in innovation and using technology to help people. However, as some whose sibling has a disability, I thought about how the advancement of gene editing pushes the narrative that those with disabilities need ‘fixing’. Therefore, I decided to research the topic further.

First of all, what is gene editing?

Gene editing is the process of deleting, inserting or replacing genetic material within animals, plants and bacteria to alter their characteristics. It has different applications, but I’m focusing on gene therapy and using different techniques to treat diseases. The development of CRISPR-Cas9 has created a quicker, cheaper method for gene editing, leading to the current buzz around the topic.

Laws surrounding gene editing:

While it is illegal in the UK to implant a gene-edited embryo, in 2016, the HFEA approved licensing to allow gene editing of human embryos in research. Many of my classmates thought this was a good change as it could lead to more knowledge and potential cures about inheritable disorders like Cystic Fibrosis. However, is this any different from previous attempts in eugenics? The removal of genetics at an embryonic level will lead to the eradication of different, ‘undesirable’, traits from society. The practice may also lead to the relaxation of laws and the possibility of designer babies.

Gene therapy case:

While gene editing is often associated with inheritable disorders, it can be used to cure cancer. There have been successful results from a study in 2010, where a patient suffering from lymphoma underwent CAR T cell therapy. In this treatment, the patients T cells are collected and then genetically altered in the laboratory so they can recognise the cancerous cells. They are then put back inside the body to fight the cancerous cells.

Image of CAR T-Cell Therapy

Cost of gene editing:

However, gene therapies are expensive! In the US it is estimated that $20.4 billion is spent annually on gene therapies. If this money was spent on creating a more inclusive environment through education of the public and the changing of laws, this could have a far greater effect on the people already living with genetic disorders. Is it not better to create an environment where people can live well with these disorders, then create one which focuses on their removal?

Different opinions:

The NHGRI conducted surveys to investigate patient perspectives on gene editing. Many patients, especially those with Huntington’s, argued that gene editing should be used to prevent other people from inheriting the disease, despite the argument that it could isolate them from society and reinforce the belief that people with disabilities have a low quality of life.

Furthermore, Wellcome Connecting Science hosted a citizen’s jury vote based on the following question: ‘Are there any circumstances under which a UK Government should consider changing the law to allow intentional genome editing of human embryos for serious genetic conditions?’. All the jurors had been affected in one way or another by hereditary diseases and by the end most jurors (17-4) agreed that human embryos should be edited. While a small sample, this vote indicates that the scientific community and the legislators are listening to those who it truly affects, something which has previously been overlooked and distinguishes gene editing from previous, eugenic practices.

Final Thoughts

My summary of different arguments for and against Gene-Editing

I believe that the advancement of gene editing will help those with genetic disorders and provides cures which were previously unavailable. I think that this outweighs the negatives of gene editing especially considering many people with genetic disorders believe in the benefits. However, I think that the narrative surrounding gene editing needs to include those who are affected the most to make sure that it is continuing to be done in a positive way which doesn’t isolate people or become modern-day eugenics.

Can we sell medical waste?

Immortal cells

I recently read The Immortal Life of Henrietta Lacks by Rebecca Skloot1; the remarkable story of an American woman whose cervical cancer was used to make the first immortal cell line, HeLa. In vitro cell research is normally constrained by the Hayflick limit2; cell lines die out after a few days. Lacks’ cancer was so aggressive that its cells could divide indefinitely, providing an invaluable biological material still used today. Incredibly, few know her name. The cells were used without her knowledge or consent, and her family knew nothing for twenty years.

This story raises important questions about human tissue ownership, notably: who owns medical waste, and can it be sold? Skloot heavily implies that the Lacks family should be compensated for Henrietta’s cells, but I’m not sure it’s so simple.

A video by Hank Green on SciShow, with further information about immortal cell lines and HeLa cells.3

Tissue ownership in the UK

My friend works for the Southampton Imaging4 group and routinely uses femoral heads, leftover from hip replacement surgery, in his research. Recently introduced to tissue ethics, I had several questions for him. My Gran had a hip replacement – are scientists experimenting on her bone? Could they extract stem cells from the marrow and make a cell line like HeLa?

Thankfully, the Human Tissue Act 20045 (HTA) restricts research on tissue to licensed labs and requires informed consent from all donors. My friend assures me that strict protocols are followed, from surgery to the lab to disposal, and that his lab must comply with the Declaration of Helsinki6.

What does this mean for Lacks’ family?

Henrietta Lacks was treated unethically. Her cells should not have been used without her consent, violating her dignity when she was extremely vulnerable. Furthermore, it’s now possible to sequence HeLa’s genome, raising concerns about Lacks’ and (her family’s) privacy. Unfortunately she died in 1951, before widespread adoption of informed consent as best practice.

Henrietta Lacks. Photo from the National Geographic7

In her book, Skloot implies that Lacks’ family should be paid for the cells. It’s important to note that HeLa cells are not full organs, nor were they healthy – if not for their scientific usefulness they would have been deemed medical waste. In the US it is illegal8 to sell one’s organs, but consent and payment law for other tissue is more permissive than in the UK, where selling human tissue is banned.

I strongly support the UK position that selling human tissue for money, regardless of purpose or usefulness, is unacceptable. Tissue derived from a person’s body deserves to be treated with more dignity than a mere commodity.

Even if the act of selling one’s own tissue were ethical, a culture that allows it is not. It would encourage objectification of the human body and provide incentive for organ theft. Nobody should have to resort to selling their tissue. Meixuan Li’ 9 wrote a post exploring this concept taken to a dystopian extreme; prisoners exchanging their organs for reduced sentences. The very idea is abhorrent.

This is why, while Henrietta Lacks was wronged, her family should not be financially compensated. Payment for human tissue, even retrospectively, is morally unacceptable.

Sources

  1. Skloot R. The Immortal Life of Henrietta Lacks. Crown Publishing Group (2010) ↩︎
  2. Hayflick’s handy guide to immortality and cell senescence. The Genetics of Basic Things and Stuff. 30th November 2022 (cited 24th March 2025). Video: 5:13 min. Available from: https://www.youtube.com/watch?v=w5SBZOa_qAg ↩︎
  3. Immortal Cells Turn 96. SciShow. 1st August 2016 (cited 20th March 2025). Video: 4:41 min. Available from: https://www.youtube.com/watch?v=sXY6-wLesYY ↩︎
  4. Southampton Imaging. University of Southampton (cited 21st March 2025). Available from: https://www.southampton.ac.uk/research/institutes-centres/southampton-imaging ↩︎
  5. Legislation. Human Tissue Authority (cited 21st March 2025). Available from: https://www.hta.gov.uk/guidance-professionals/codes-practice-standards-and-legislation/legislation ↩︎
  6. WMA Declaration of Helsinki – Ethical Principles for Medical Research involving Human Participants. World Medical Association. 2024. (cited 21st March 2025). Available from: https://www.wma.net/policies-post/wma-declaration-of-helsinki/ ↩︎
  7. Marc Silver. A New Chapter in the Immortal Life of Henrietta Lacks. National Geographic. 2013 (cited 21st March 2025). Available from: https://www.nationalgeographic.com/science/article/130816-henrietta-lacks-immortal-life-hela-cells-genome-rebecca-skloot-nih ↩︎
  8. Can you sell organs in the United States? Donor Alliance; Tissue and Organ Donation. 2025. (cited 21st March 2025). Available from: https://www.donoralliance.org/newsroom/donation-essentials/can-you-sell-organs/ ↩︎
  9. Li M. Prisoners ‘Donating’ Organs for Sentence Reduction: Should the Punishment Fit the Crime? 12th March 2025 (cited 21st March 2025). In: Engineering Replacement Body Parts 2024-2025. Available from: https://generic.wordpress.soton.ac.uk/uosm2031-2025/2025/03/12/prisoners-donating-organs-for-sentence-reduction-should-the-punishment-fit-the-crime-2/ ↩︎